Latest Content

Learn about Kaposi sarcoma causes, symptoms and the latest treatment options to help you navigate your diagnosis and talk with your oncologist.

Learn about stage 2 chronic myeloid leukemia, treatment options, side effects, and key questions to guide conversations with your oncologist.

Dr. Rodney Haring discusses strategies to reduce cancer mortality among Native Americans through patient navigation, clinical trials and tribal sovereignty.

Dr. Alex Francoeur of UC Irvine urges patients with ovarian cancer to ask questions, seek second opinions and build trusted relationships with oncologists.

A study led by Dr. J. William Harbour of UT Southwestern Medical Center marks a shift in how doctors predict the spread of uveal melanoma.

Gratitude didn’t erase my fear, but it gave me something solid to stand on. It became the coping strategy I needed.

Heather Quintana Suchan shares how work and music community support her while she lives fully with stage 4 lung cancer.

Dr. Sara Tolaney discusses how Trodelvy plus Keytruda improves progression-free survival in patients with PD-L1+ metastatic triple-negative breast cancer.

FDA approves Calquence with Venclexta as a first-line option that improved progression-free survival compared with standard chemo in adults with CLL or SLL.

Researchers identified nine genetic markers that help HER2-positive breast cancer resist treatment, paving the way for more personalized patient care.

App-based self-acupressure improved fatigue and quality of life for women with ovarian cancer in a phase 3 trial, with benefits lasting to 24 weeks.

This device detects and characterizes lesions on low-dose CT scans, helping patients with cancer get faster, tailored care and avoid unnecessary procedures.

Looking back over the setbacks and blessings of the roller coaster ride that was my cancer treatment journey.